Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
life sciences & biomedicine (7) 7
science & technology (7) 7
humans (5) 5
cholesterol (4) 4
cholesterol, ldl - blood (4) 4
abridged index medicus (3) 3
aged (3) 3
biomarkers - blood (3) 3
cardiovascular disease (3) 3
cardiovascular diseases (3) 3
cardiovascular diseases - prevention & control (3) 3
double-blind method (3) 3
female (3) 3
general & internal medicine (3) 3
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (3) 3
lipids (3) 3
male (3) 3
medicine, general & internal (3) 3
middle aged (3) 3
angina (2) 2
antibodies, monoclonal - adverse effects (2) 2
antibodies, monoclonal - therapeutic use (2) 2
anticholesteremic agents - adverse effects (2) 2
anticholesteremic agents - therapeutic use (2) 2
apolipoprotein b (2) 2
biological and medical sciences (2) 2
c-reactive protein (2) 2
cardiac & cardiovascular systems (2) 2
cardiovascular (2) 2
cardiovascular diseases - mortality (2) 2
cardiovascular system & cardiology (2) 2
cerebral infarction (2) 2
diet (2) 2
disease prevention (2) 2
drug therapy (2) 2
general aspects (2) 2
heart attacks (2) 2
hypercholesterolemia - drug therapy (2) 2
ischemia (2) 2
lipoproteins (2) 2
low density lipoprotein (2) 2
medical sciences (2) 2
mortality (2) 2
myocardial infarction (2) 2
research (2) 2
risk assessment (2) 2
secondary prevention (2) 2
statins (2) 2
stroke (2) 2
triglycerides (2) 2
triglycerides - blood (2) 2
610 medicine & health (1) 1
accf/aha competence and training statements (1) 1
acute coronary syndrome (1) 1
acute coronary syndrome - drug therapy (1) 1
acute coronary syndromes (1) 1
acute disease (1) 1
acutely (1) 1
adult (1) 1
analysis (1) 1
angina pectoris (1) 1
antibodies (1) 1
anticholesteremic agents (1) 1
apolipoprotein b-100 - blood (1) 1
apolipoproteins (1) 1
apolipoproteins - blood (1) 1
atherosclerosis (1) 1
atorvastatin (1) 1
atorvastatin calcium (1) 1
attitude to health (1) 1
azetidines - therapeutic use (1) 1
babies (1) 1
behavior (1) 1
biological markers (1) 1
biomarkers (1) 1
blood pressure (1) 1
blood pressure - drug effects (1) 1
c-reactive protein - analysis (1) 1
cardiac (1) 1
cardiac rehabilitation (1) 1
cardiocentro ticino (1) 1
cardiology and cardiovascular medicine (1) 1
cardiology. vascular system (1) 1
cardiovascular agents (1) 1
care and treatment (1) 1
catalytic converters (1) 1
child health services - organization & administration (1) 1
childbirth & labor (1) 1
children (1) 1
cholesterol ester transfer proteins (1) 1
cholesterol ester transfer proteins - antagonists & inhibitors (1) 1
cholesterol, hdl (1) 1
cholesterol, hdl - blood (1) 1
cholesterol, ldl (1) 1
cholesteryl ester transfer protein (1) 1
clinical medicine (1) 1
clinical protocols (1) 1
clinical trials (1) 1
closeness (1) 1
collaborative decision making (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Nitrous Oxide Emissions from Light Duty Vehicles
by Ballantyne, Vera F., author
SAE technical paper series, Volume 940304.
Exhaust emissions | Nitrogen oxides | Tests and Testing | Catalytic converters | Emissions
eJournal
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists
by Davidson, Michael H., MD, FNLA, Chair and Ballantyne, Christie M., MD, FNLA, Co-Chair, Inflammatory Biomarkers Sub-group and Jacobson, Terry A., MD, FNLA, Co-Chair, Lipoprotein Biomarkers Sub-group and Bittner, Vera A., MD, MSPH, FNLA and Braun, Lynne T., PhD, CNP, FNLA and Brown, Alan S., MD, FNLA and Brown, W.Virgil, MD, FNLA and Cromwell, William C., MD, FNLA and Goldberg, Ronald B., MD, FNLA and McKenney, James M., PharmD, FNLA and Remaley, Alan T., MD, PhD and Sniderman, Allan D., MD and Toth, Peter P., MD, PhD, FNLA and Tsimikas, Sotirios, MD and Ziajka, Paul E., MD, PhD, FNLA and Maki, Kevin C., Non-Panel Scientists and Dicklin, Mary R., PhD
Journal of clinical lipidology, ISSN 1933-2874, 2011, Volume 5, Issue 5, pp. 338 - 367
Cardiovascular | Apolipoprotein B | Lipoprotein-associated phospholipase A2 | Lipoprotein(a) | C-reactive protein | Lipoprotein subfractions | Low-density lipoprotein particle concentration | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Risk Assessment | Cardiovascular Diseases - prevention & control | Humans | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Cholesterol, LDL - blood | Biomarkers - blood | Hypercholesterolemia - drug therapy | Practice Guidelines as Topic | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
by Bhatt, Deepak L and Steg, P. Gabriel and Miller, Michael and Brinton, Eliot A and Jacobson, Terry A and Ketchum, Steven B and Doyle, Ralph T and Juliano, Rebecca A and Jiao, Lixia and Granowitz, Craig and Tardif, Jean-Claude and Ballantyne, Christie M and REDUCE-IT Investigators
The New England journal of medicine, ISSN 0028-4793, 01/2019, Volume 380, Issue 1, pp. 11 - 22
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hypertriglyceridemia - drug therapy | Double-Blind Method | Drug Administration Schedule | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Eicosapentaenoic Acid - analogs & derivatives | Humans | Middle Aged | Risk Factors | Kaplan-Meier Estimate | Male | Secondary Prevention | Incidence | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Triglycerides - blood | Cardiovascular Diseases - mortality | Female | Aged | Eicosapentaenoic Acid - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Myocardial infarction | Cerebral infarction | Stroke | Heart attacks | Diabetes mellitus | Angina | Angina pectoris | Risk factors | Cholesterol | Disease prevention | Fibrillation | Ischemia | Hypertriglyceridemia | Death | Cardiovascular diseases | Health risk assessment | Eicosapentaenoic acid | Statins | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
by Schwartz, Gregory G and Olsson, Anders G and Abt, Markus and Ballantyne, Christie M and Barter, Philip J and Brumm, Jochen and Chaitman, Bernard R and Holme, Ingar M and Kallend, David and Leiter, Lawrence A and Leitersdorf, Eran and McMurray, John J.V and Mundl, Hardi and Nicholls, Stephen J and Shah, Prediman K and Tardif, Jean-Claude and Wright, R. Scott and dal-OUTCOMES Investigators
The New England journal of medicine, ISSN 0028-4793, 11/2012, Volume 367, Issue 22, pp. 2089 - 2099
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Heart | General aspects | Biological and medical sciences | Myocarditis. Cardiomyopathies | Medical sciences | Coronary heart disease | Cholesterol Ester Transfer Proteins - antagonists & inhibitors | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Risk | Secondary Prevention | Biomarkers - blood | Apolipoproteins - blood | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - drug therapy | Sulfhydryl Compounds - adverse effects | Anticholesteremic Agents - therapeutic use | Triglycerides - blood | Cardiovascular Diseases - mortality | Cholesterol, HDL - blood | Cholesterol, LDL - blood | Female | Aged | Blood Pressure - drug effects | Sulfhydryl Compounds - therapeutic use | C-Reactive Protein - analysis | Measurement | Cholesterol, HDL | Patient outcomes | Dosage and administration | Research | Acute coronary syndrome | Drug therapy | Health aspects | Cardiovascular agents | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | C-reactive protein | Heart attacks | Mortality | Cardiovascular disease | Angina | Coronary artery disease | Cholesterol | Cholesteryl ester transfer protein | Studies | Ischemia | Diet | Biomarkers | Blood pressure | Acute coronary syndromes | Cardiovascular diseases | Heart diseases | Lipoproteins (high density) | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia
by Blom, Dirk J and Hala, Tomas and Bolognese, Michael and Lillestol, Michael J and Toth, Phillip D and Burgess, Lesley and Ceska, Richard and Roth, Eli and Koren, Michael J and Ballantyne, Christie M and Monsalvo, Maria Laura and Tsirtsonis, Kate and Kim, Jae B and Scott, Rob and Wasserman, Scott M and Stein, Evan A and DESCARTES Investigators
The New England journal of medicine, ISSN 0028-4793, 05/2014, Volume 370, Issue 19, pp. 1809 - 1819
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | Metabolic diseases | General aspects | Medical sciences | Disorders of blood lipids. Hyperlipoproteinemia | Proprotein Convertases - antagonists & inhibitors | Double-Blind Method | Heptanoic Acids - therapeutic use | Humans | Hyperlipidemias - drug therapy | Middle Aged | Antibodies, Monoclonal - adverse effects | Ezetimibe | Antibodies, Monoclonal - therapeutic use | Male | Combined Modality Therapy | Proprotein Convertases - immunology | Atorvastatin Calcium | Azetidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Serine Endopeptidases - immunology | Least-Squares Analysis | Adult | Cholesterol, LDL - blood | Female | Aged | Hyperlipidemias - diet therapy | Pyrroles - therapeutic use | Proprotein Convertase 9 | Monoclonal antibodies | Clinical trials | Care and treatment | Product development | Research | Hyperlipidemia | Lipoproteins (low density) | Nutrient deficiency | Rhinopharyngitis | Ultracentrifugation | Subtilisin | Triglycerides | Patients | Low density lipoprotein | Cholesterol | Apolipoprotein B | Kexin | Pain | Diet | Influenza | Atorvastatin | Respiratory tract diseases | Drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text ACCF/AHA/ACP 2009 Competence and Training Statement: A Curriculum on Prevention of Cardiovascular Disease
by Bairey Merz, C. Noel and Alberts, Mark J and Balady, Gary J and Ballantyne, Christie M and Berra, Kathy and Black, Henry R and Blumenthal, Roger S and Davidson, Michael H and Fazio, Sara B and Ferdinand, Keith C and Fine, Lawrence J and Fonseca, Vivian and Franklin, Barry A and McBride, Patrick E and Mensah, George A and Merli, Geno J and O'Gara, Patrick T and Thompson, Paul D and Underberg, James A and American College of Cardiology Foundation and American Association of Cardiovascular and Pulmonary Rehabilitation and American College of Preventive Medicine and American Academy of Neurology and American Diabetes Association and American Society of Hypertension and National Lipid Association and American Heart Association and American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Competence and Training Statement on Prevention of Cardiovascular Disease) and Association of Black Cardiologists and Preventive Cardiovascular Nurses Association and ACCF AHA ACP
Journal of the American College of Cardiology, ISSN 0735-1097, 09/2009, Volume 54, Issue 14, pp. 1336 - 1363
competency | training | ACCF/AHA Competence and Training Statements | cardiovascular | vascular | prevention | cardiac rehabilitation | cardiac | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Hypertension | Task forces | Mortality | Cardiovascular disease | Lipids | Preventive medicine | Primary care | Thrombosis | Disease prevention | Risk assessment | Nurses | Atherosclerosis | Writing | Behavior | Clinical medicine | Diabetes | Rehabilitation | Pharmaceutical industry
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights